According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is $3.27 Million USD. a decrease over the revenue in the year 2023 that were of $0.08 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.